JP2021528411A5 - - Google Patents
Info
- Publication number
- JP2021528411A5 JP2021528411A5 JP2020570569A JP2020570569A JP2021528411A5 JP 2021528411 A5 JP2021528411 A5 JP 2021528411A5 JP 2020570569 A JP2020570569 A JP 2020570569A JP 2020570569 A JP2020570569 A JP 2020570569A JP 2021528411 A5 JP2021528411 A5 JP 2021528411A5
- Authority
- JP
- Japan
- Prior art keywords
- lif
- amino acid
- acid sequence
- seq
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18382433.3 | 2018-06-18 | ||
| EP18382433 | 2018-06-18 | ||
| PCT/IB2019/000756 WO2019243893A1 (en) | 2018-06-18 | 2019-06-17 | Methods of quantifying lif and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021528411A JP2021528411A (ja) | 2021-10-21 |
| JP2021528411A5 true JP2021528411A5 (https=) | 2022-06-24 |
| JP7570929B2 JP7570929B2 (ja) | 2024-10-22 |
Family
ID=62716028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020570569A Active JP7570929B2 (ja) | 2018-06-18 | 2019-06-17 | Lifを定量化する方法及びその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210190798A1 (https=) |
| EP (1) | EP3806960A1 (https=) |
| JP (1) | JP7570929B2 (https=) |
| CN (1) | CN112654395A (https=) |
| WO (1) | WO2019243893A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021057991A1 (zh) * | 2019-09-29 | 2021-04-01 | 北京加科思新药研发有限公司 | 对lif具有特异性的结合分子及其用途 |
| EP4069736A1 (en) * | 2019-12-04 | 2022-10-12 | MedImmune Limited | Antibodies against lif and uses thereof |
| CN116298320B (zh) * | 2023-03-31 | 2025-07-11 | 深圳迈瑞生物医疗电子股份有限公司 | 检测白血病抑制因子的试剂盒及检测方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011057144A2 (en) * | 2009-11-06 | 2011-05-12 | La Jolla Institute For Allergy And Immunology | Methods for modulating lif activity, treating immune disorders and diseases, and stimulatings immune responses |
| US20160237158A1 (en) * | 2013-09-23 | 2016-08-18 | Institut National De La Santé Et Da La Recherche Médicale (Inserm) | Methods and Compositions for Targeting Tumor Microenvironment and for preventing Metastasis |
| US10583191B2 (en) * | 2016-12-19 | 2020-03-10 | Mosaic Biomedicals Slu | Antibodies against LIF and uses thereof |
-
2019
- 2019-06-17 CN CN201980053683.8A patent/CN112654395A/zh active Pending
- 2019-06-17 US US17/252,476 patent/US20210190798A1/en not_active Abandoned
- 2019-06-17 WO PCT/IB2019/000756 patent/WO2019243893A1/en not_active Ceased
- 2019-06-17 EP EP19779092.6A patent/EP3806960A1/en active Pending
- 2019-06-17 JP JP2020570569A patent/JP7570929B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010298036B2 (en) | Screening methods | |
| DK2556090T3 (en) | Soluble, human st-2 antibodies and assays | |
| JP2022115986A5 (https=) | ||
| US10114028B2 (en) | Biomarkers for pneumonia and acute decompensated heart failure | |
| JP2016505634A5 (https=) | ||
| JP6138780B2 (ja) | 癌の検出および診断のための抗体i−3859の使用 | |
| JP2021528411A5 (https=) | ||
| US20240092925A1 (en) | Cd5-targeting fully humanized antibody | |
| Weeraratne et al. | Development of a biosensor-based immunogenicity assay capable of blocking soluble drug target interference | |
| KR102017241B1 (ko) | C-반응성 단백질에 특이적으로 결합하는 항체 및 이의 용도 | |
| RU2019110953A (ru) | Моноклональное антитело, специфически связывающееся с тиоредоксином-1, и его применение | |
| AU2016333540A1 (en) | GDF-15 as a diagnostic marker for melanoma | |
| Park et al. | Evolutionary identification of affinity peptides for the detection of sepsis biomarker procalcitonin | |
| JP2022538688A5 (https=) | ||
| JP2007513873A5 (https=) | ||
| JP2005522228A5 (https=) | ||
| JP2022506108A5 (https=) | ||
| JPWO2024070874A5 (https=) | ||
| CN114891108A (zh) | 一种靶向bcma的全人源抗体及其应用 | |
| KR102836238B1 (ko) | 샘플에서 항체의 유리 항원 측정 방법 | |
| CA2771954A1 (en) | Pneumonia biomarkers | |
| Li et al. | Selection of potential cytokeratin-18 monoclonal antibodies following IGH repertoire evaluation in mice | |
| JP2020501162A5 (https=) | ||
| WO2018213680A1 (en) | Diagnostic antibodies and methods of use | |
| WO2017201440A1 (en) | Anti-ascl1 antibodies and methods of use |